{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T21:27:33Z","timestamp":1786224453698,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12328-022-01695-5","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T18:02:25Z","timestamp":1662400945000},"page":"1035-1040","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Combination of photodynamic therapy and endoscopic mucosal resection for recurrent esophageal squamous cell carcinoma after chemoradiotherapy"],"prefix":"10.1007","volume":"15","author":[{"given":"Hidenori","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-1557","authenticated-orcid":false,"given":"Takuto","family":"Hikichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunetaka","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minami","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichiro","family":"Kobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Yanagita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Takasumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Kobayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"1695_CR1","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.ijrobp.2005.10.015","volume":"64","author":"K Yamada","year":"2006","unstructured":"Yamada K, Murakami M, Okamoto Y, et al. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2006;64:1106\u201311.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1695_CR2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/jjco\/hyp069","volume":"398","author":"H Kato","year":"2009","unstructured":"Kato H, Sato A, Fukuda H, et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol. 2009;398:638\u201343.","journal-title":"Jpn J Clin Oncol"},{"key":"1695_CR3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ijrobp.2010.06.033","volume":"81","author":"K Kato","year":"2011","unstructured":"Kato K, Muro K, Minashi K, et al. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II\u2013III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys. 2011;81:684\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1695_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/dote.12215","volume":"28","author":"E Versteijne","year":"2015","unstructured":"Versteijne E, van Laarhoven HW, van Hooft JE, et al. Definitive chemoradiation for patients with inoperable and\/or unresectable esophageal cancer: locoregional recurrence pattern. Dis Esophagus. 2015;28:453\u20139.","journal-title":"Dis Esophagus"},{"key":"1695_CR5","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.2147\/CMAR.S198524","volume":"11","author":"M Chen","year":"2019","unstructured":"Chen M, Liu P, Chen Y, et al. Primary tumor regression patterns in esophageal squamous cell cancer treated with definitive chemoradiotherapy and implications for surveillance schemes. Cancer Manag Res. 2019;11:3361\u20139.","journal-title":"Cancer Manag Res"},{"key":"1695_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000480515","volume":"94","author":"K Sudo","year":"2018","unstructured":"Sudo K, Kato K, Kuwabara H, et al. Patterns of relapse after definitive chemotherapy in stage II\/III (Non-T4) esophageal squamous cell carcinoma. Oncology. 2018;94:47\u201354.","journal-title":"Oncology"},{"key":"1695_CR7","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1200\/JCO.2003.03.055","volume":"21","author":"S Ishikura","year":"2003","unstructured":"Ishikura S, Nihei K, Ohtsu A, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol. 2003;21:2697\u2013702.","journal-title":"J Clin Oncol"},{"key":"1695_CR8","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.jtcvs.2013.12.040","volume":"147","author":"S Wang","year":"2014","unstructured":"Wang S, Tachimori Y, Hokamura N, et al. Prognostic analysis of salvage esophagectomy after definitive chemoradiotherapy for esophageal squamous cell carcinoma: the importance of lymphadenectomy. J Thorac Cardiovasc Surg. 2014;147:1805\u201311.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1695_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1442-2050.2012.01440.x","volume":"27","author":"Y Chen","year":"2014","unstructured":"Chen Y, Lu Y, Wang Y, et al. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone. Dis Esophagus. 2014;27:134\u201340.","journal-title":"Dis Esophagus"},{"key":"1695_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jtcvs.2008.05.016","volume":"137","author":"Y Tachimori","year":"2009","unstructured":"Tachimori Y, Kanamori N, Uemura N, et al. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2009;137:49\u201354.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1695_CR11","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3109\/00365521.2013.822092","volume":"48","author":"M Takeuchi","year":"2013","unstructured":"Takeuchi M, Kobayashi M, Hashimoto S, et al. Salvage endoscopic submucosal dissection in patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Scand J Gastroenterol. 2013;48:1095\u2013101.","journal-title":"Scand J Gastroenterol"},{"key":"1695_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/dote.12037","volume":"27","author":"M Makazu","year":"2014","unstructured":"Makazu M, Kato K, Takisawa H, et al. Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer. Dis Esophagus Dis Esophagus. 2014;27:42\u20139.","journal-title":"Dis Esophagus Dis Esophagus"},{"key":"1695_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1055\/s-2008-1077480","volume":"40","author":"T Yano","year":"2008","unstructured":"Yano T, Muto M, Hattori S, et al. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy. 2008;40:717\u201321.","journal-title":"Endoscopy"},{"key":"1695_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10388-014-0430-z","volume":"11","author":"S Matono","year":"2014","unstructured":"Matono S, Fujita H, Tanaka T, et al. Salvage lymphadenectomy without esophagectomy is an option for recurrent or residual lymph nodes after definitive chemoradiotherapy for esophageal cancer. Esophagus. 2014;11:197\u2013203.","journal-title":"Esophagus"},{"key":"1695_CR15","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/jso.20475","volume":"93","author":"Y Tomimaru","year":"2006","unstructured":"Tomimaru Y, Yano M, Takachi K, et al. Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy. J Surg Oncol. 2006;93:422\u20138.","journal-title":"J Surg Oncol"},{"key":"1695_CR16","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.ejcts.2008.01.056","volume":"33","author":"XB D'Journo","year":"2008","unstructured":"D\u2019Journo XB, Michelet P, Dahan L, et al. Indications and outcome of salvage surgery for oesophageal cancer. Eur J Cardiothorac Surg. 2008;33:1117\u201323.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1695_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.amjsurg.2004.06.003","volume":"188","author":"T Nakamura","year":"2004","unstructured":"Nakamura T, Hayashi K, Ota M, et al. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg. 2004;188:261\u20136.","journal-title":"Am J Surg"},{"key":"1695_CR18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.gie.2013.09.012","volume":"79","author":"S Koizumi","year":"2014","unstructured":"Koizumi S, Jin M, Matsuhashi T, et al. Salvage endoscopic submucosal dissection for the esophagus-localized recurrence of esophageal squamous cell cancer after definitive chemoradiotherapy. Gastrointest Endosc. 2014;79:348\u201353.","journal-title":"Gastrointest Endosc"},{"key":"1695_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13014-016-0604-z","volume":"11","author":"K Hatogai","year":"2016","unstructured":"Hatogai K, Yano T, Kojima T, et al. Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer. Radiat Oncol. 2016;11:31.","journal-title":"Radiat Oncol"},{"key":"1695_CR20","doi-asserted-by":"publisher","first-page":"22135","DOI":"10.18632\/oncotarget.14029","volume":"8","author":"T Yano","year":"2017","unstructured":"Yano T, Kasai H, Horimatsu T, et al. A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer. Oncotarget. 2017;8:22135\u201344.","journal-title":"Oncotarget"},{"key":"1695_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1055\/s-0030-1256373","volume":"43","author":"T Yano","year":"2011","unstructured":"Yano T, Muto M, Minashi K, et al. Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy. 2011;43:657\u201363.","journal-title":"Endoscopy"},{"key":"1695_CR22","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/ijc.27320","volume":"131","author":"T Yano","year":"2012","unstructured":"Yano T, Muto M, Minashi K, et al. Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma: a phase II study. Int J Cancer. 2012;131:1228\u201334.","journal-title":"Int J Cancer"},{"key":"1695_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/php.13206","volume":"96","author":"T Yano","year":"2020","unstructured":"Yano T, Wang KK. Photodynamic therapy for gastrointestinal cancer. Photochem Photobiol. 2020;96:517\u201323.","journal-title":"Photochem Photobiol"},{"key":"1695_CR24","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.3390\/jcm10132785","volume":"10","author":"T Yano","year":"2021","unstructured":"Yano T, Minamide T, Takashima K, et al. Clinical practice of photodynamic therapy using talaporfin sodium for esophageal cancer. J Clin Med. 2021;10:2785.","journal-title":"J Clin Med"},{"key":"1695_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/den.13730","volume":"33","author":"Y Amanuma","year":"2021","unstructured":"Amanuma Y, Horimatsu T, Ohashi S, et al. Association of local complete response with prognosis after salvage photodynamic therapy for esophageal squamous cell carcinoma. Dig Endosc. 2021;33:355\u201363.","journal-title":"Dig Endosc"},{"key":"1695_CR26","first-page":"727","volume":"215","author":"H Narahara","year":"2005","unstructured":"Narahara H. Photodynamic therapy for gastric cancer. Igaku no Ayumi. 2005;215:727\u20139 (in Japanese).","journal-title":"Igaku no Ayumi"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-022-01695-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-022-01695-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-022-01695-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T18:30:26Z","timestamp":1669401026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-022-01695-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1695"],"URL":"https:\/\/doi.org\/10.1007\/s12328-022-01695-5","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"assertion":[{"value":"29 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hidenori Sato, Takuto Hikichi, Tsunetaka Kato, Jun Nakamura, Minami Hashimoto, Ryoichiro Kobashi, Takumi Yanagita, Mika Takasumi, Masao Kobayakawa, and Hiromasa Ohira declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from these patient for being included in the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}}]}}